[ET Net News Agency, 7 January 2020] China Touyun Tech Group Limited (01332) said the
company has entered into a scale-up program and licence agreement with Triton Algae
Innovations, Ltd. (Triton) in respect of granting to the group a non-exclusive licence to
the Triton Acetate Process and Triton Green Strain and for the group to conduct a pilot
production and scale-up manufacturing program.
Triton Acetate Process means Triton's proprietary fermentation process utilizing acetate
as the carbon source in feedstocks. Such process is transferred to the group under the
technology transfer to enable the group to utilize and scale-up the manufacture of product
under the program.
Triton Green Strain means Triton's proprietary chlamydomonas reinhardtii green colour
algae strain, such chlamydomonas reinhardtii contains proteins, unsaturated fatty acid,
omega 3, vitamin A and polysaccharide, and was recognized by U.S. Food and Drug
Administration (FDA) as GRAS, i.e. generally recognized as safe. (RC)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.230 0.000 (0.000%) Others
07/01/2020 14:37
China Touyun (01332) signs licence agreement with Triton
| Remark: | Real time quote last updated: 25/04/2024 08:47 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |